medigraphic.com
SPANISH

Revista Médica de la Universidad Autónoma de Sinaloa REVMEDUAS

ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 2

<< Back Next >>

Rev Med UAS 2023; 13 (2)

Maternal and perinatal impact of urinary tract infection in pregnancy: a review

Jacobo-Gallardo AK, Báez-Barraza J, Quevedo-Castro E, Morgan-Ruiz F, López-Manjarrez G, Gutiérrez-Arzapalo PY, Morgan-Ortiz F
Full text How to cite this article

Language: Spanish
References: 25
Page: 201-216
PDF size: 224.64 Kb.


Key words:

Urinary infection, Asymptomatic bacteriuria, Pregnancy, Cystitis, Acute pyelonephritis.

ABSTRACT

The second most frequent pathology found in pregnant women is urinary tract infections, posing a great therapeutic challenge due to the maternal and fetal compromise that they can cause. During pregnancy there are functional, structural and physiological changes of the urinary tract, these changes promote the invasion of germs from the urethra and the development of urinary pathology. Therefore, all pregnant women should undergo asymptomatic bacteriuria screening by urine culture, and if positive, always receive antimicrobial treatment, as it is an important risk factor for the development of Pyelonephritis during pregnancy, unlike of the non-pregnant woman.


REFERENCES

  1. Sánchez GC. Valor Predictivo del Urocultivoen el diagnóstico de las complicaciones obstétricasy neonatales, en gestantes adolescentesy añosas atendidas en el INMP, duranteel 2011. HorizMed 2013; 13 ():122–135.

  2. Martínez E, Osorio J, Delgado J, Esparza G.Infecciones del tracto urinario bajo en adultosy embarazadas: consenso para el manejoempírico. Infection. 2013;17(3):122–135.

  3. Vallejos C, López M, Enríquez M. Prevalenciade infecciones de vías urinarias en embarazadasatendidas en el Hospital Universitariode Puebla. Enf Inf Microbiol 2010 30(4): 118-12.

  4. Szweda H, Jóźwik M. Urinary tract infectionsduring pregnancy – an updated overview.Dev Period Med. 2016;20(4):263-272.

  5. Smaill FM, Vazquez JC. Antibiotics forasymptomatic bacteriuria in pregnancy. CochraneDatabase Syst Rev. 2019(11)

  6. Schnarr J, Smaill F. Asymptomatic bacteriuriaand symptomatic urinary tract infectionsin pregnancy. Eur J Clin Invest. 2008;38Suppl 2:50-57

  7. Wing DA, Fassett MJ, Getahun D. Acutepyelonephritis in pregnancy: an 18-year retrospectiveanalysis. Am J Obstet Gynecol.2014;210(3)

  8. Angelescu K, Nussbaumer B, Sieben W,Scheibler F, Gartlehner G. Benefits andharms of screening for and treatment ofasymptomatic bacteriuria in pregnancy: asystematic review. BMC PregnancyChildbirth. 2016; 16(1):336.

  9. Kazemier BM, Koningstein FN, SchneebergerC. Maternal and neonatal consequencesof treated and untreated asymptomatic bacteriuriain pregnancy: a prospective cohortstudy with an embedded randomised controlledtrial. Lancet In fect Dis. 2015;15(11):1324-1333.

  10. Acosta TJ, Ramos MA, Zamora AL, MurilloL. Prevalence of urinary tract infection inhospitalized patients with preterm labor. GinecolObstet Mex. 2014 Nov; 82(11):737-43.

  11. Bacterial Diseases, National Center for Immunizationand Respiratory Diseases, Centersfor Disease Control and Prevention(CDC). Prevention of perinatal group Bstreptococcal disease revised guidelinesfrom CDC, 2010. MMWR Recomm Rep.2010; 59(RR-10):1-36.

  12. Newton E. Preterm labor, preterm prematurerupture of membranes, and chorioamnionitis.Clin Perinatol. 2005; 32(3):571-600.

  13. Hill JB, Sheffield JS, McIntire DD, WendelGD. Acute pyelonephritis in pregnancy. ObstetGynecol. 2005; 105(1):18-23.

  14. Wing DA, Fassett MJ, Getahun D. Acutepyelonephritis in pregnancy: an 18-year retrospectiveanalysis. Am J Obstet Gynecol.2014 Mar;210(3):219.e1-6

  15. Teppa RJ, Roberts JM. The Uriscreen Testto detect signicant asymptomatic bacteriuriaduring pregnancy. J Soc Gynecol Investig,2005, 12, 50-53.

  16. Nicolle LE, Gupta K, Bradley SF, et al. ClinicalPractice Guideline for the Managementof Asymptomatic Bacteriuria: 2019 Updateby the Infectious Diseases Society of America.Clin Infect Dis. 2019;68(10):1611-1615

  17. Salvatore S, Salvatore S, Cattoni E. Urinarytract infections in women. Eur J Obstet GynecolReprod Biol. 2011;156(2):131-136.

  18. Rossi P, Cimerman S, Truzzi JC, CunhaCAD, Mattar R, Martino MD, et al. Joint reportof SBI (Brazilian Society of Infectious Diseases),FEBRASGO (Brazilian Federationof Gynecology and Obstetrics Associations),SBU (Brazilian Society of Urology) andSBPC/ML (Brazilian Society of ClinicalPathology/Laboratory Medicine): recommendationsfor the clinical management oflower urinary tract infections in pregnant andnon-pregnant women. Braz J Infect Dis.2020 Mar-Apr;24(2):110-119.

  19. Widmer M, Lopez I, Gülmezoglu AM, MigniniL, Roganti A. Duration of treatment for asymptomaticbacteriuria during pregnancy. CochraneDatabase Syst Rev. 2015 Nov11;(11).

  20. Reeves DS. Treatment of bacteriuria in pregnancywith single dose fosfomycin trometamol:a review. Infection. 1992;20 Suppl4:S313-S316.

  21. Gupta K, Hooton TM, Naber KG. Internationalclinical practice guidelines for the treatmentof acute uncomplicated cystitis andpyelonephritis in women: A 2010 update bythe Infectious Diseases Society of Americaand the European Society for Microbiologyand Infectious Diseases. Clin Infect Dis.2011;52(5):e103-e120.

  22. Wing DA. Pyelonephritis in pregnancy: treatmentoptions for optimal outcomes. Drugs.2001;61(14):2087-2096.

  23. Ennis M, Callaway L, Lust K. Adherence toevidence-based guidelines for the managementof pyelonephritis in pregnancy. Aust NZ J Obstet Gynaecol. 2011 Dec;51(6):505-9.

  24. Glaser AP, Schaeffer AJ. Urinary Tract Infectionand Bacteriuria in Pregnancy. UrolClin North Am. 2015;42(4):547-560.

  25. Matuszkiewicz-Rowińska J, Małyszko J,Wieliczko M. Urinary tract infections in pregnancy:old and new unresolved diagnosticand therapeutic problems. Arch Med Sci.2015 Mar 16;11(1):67-77.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med UAS. 2023;13